Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus warfarin during catheter ablation for atrial fibrillation or atrial flutter
ChiCTR-OPN-15006584Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rivaroxaban and warfarin in Atrial fibrillation (AFib) and atrial flutter (AFL) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Coagulation indicator. Started Jun 2015; status: recruiting.
02
Drugs
rivaroxabanwarfarin
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on ChiCTR-OPN-15006584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006584.